WHO ICTRP trial
SecOnd-line Chemotherapy with RAmucirumab +/- pacliTaxel in Elderly advanced…
EUCTR2017-001683-37-FR · EU Clinical Trials Register · Authorised
Key facts
| Trial ID | EUCTR2017-001683-37-FR |
|---|---|
| Public title | SecOnd-line Chemotherapy with RAmucirumab +/- pacliTaxel in Elderly advanced gastric or gastroesophageal junction cancer patients |
| Scientific title | SecOnd-line Chemotherapy with RAmucirumab +/- pacliTaxel in Elderly advanced gastric or gastroesophageal junction cancer patients - SOCRATE |
| Primary sponsor | Fédération Francophone de Cancérologie Digestive |
| Registry | EU Clinical Trials Register |
| Recruitment status | Authorised |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): yes Therapeutic confirmatory - (Phase III): no Therapeutic use (Phase IV): no |
| Countries | France |
| Conditions | Elederly patient with advanced gastric or gastroesophageal junction cancer, after first line chemotherapy MedDRA version: 20.0 Level: LLT Classification code 10042080 Term: Stomach cancer System Organ Class: 100000004864 MedDRA version… |
| Interventions | Trade Name: Cyramza Product Name: Ramucirumab Pharmaceutical Form: Concentrate for solution for infusion INN or Proposed INN: Ramucirumab CAS Number: 947687-13-0 Other descriptive name: RAMUCIRUMAB Concentration unit: mg/ml… |
| Registration date | Jan 22, 2018 |
| Target size | 112 |
| Secondary IDs | PRODIGE55 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: